Hindustan Copper Ltd (HCL)

 

Hindustan Copper Ltd (HCL)



Share Price & Company Snapshot

Disclaimer: Share prices fluctuate continuously during market hours and may differ slightly across exchanges and trading platforms.

ЁЯУИ Current Market Snapshot

  • Exchange: NSE / BSE

  • Current Market Price (CMP): ₹___ (latest available)

  • Day’s High / Low: ₹___ / ₹___

  • 52‑Week High / Low: ₹___ / ₹___

  • Market Capitalisation: ₹___

  • Face Value: ₹___ per share

ЁЯУК Price Performance

  • 1 Day: ___%

  • 1 Week: ___%

  • 1 Month: ___%

  • 3 Months: ___%

  • 1 Year: ___%

  • 3 Years: ___%

ЁЯПн Company Overview

Hindustan Copper Limited (HCL) is a Government of India–owned Public Sector Undertaking (PSU) operating under the Ministry of Mines. The company is engaged across the complete copper value chain, including copper ore mining, beneficiation, smelting, refining, and the manufacture of copper wire rods.

HCL is India’s only vertically integrated copper producer, which makes it strategically important for the country’s industrial ecosystem, infrastructure development, and energy transition initiatives.

The company’s mining complexes and production facilities are located across Rajasthan, Madhya Pradesh, Jharkhand, and Maharashtra, helping support domestic copper requirements while reducing India’s dependence on imports.

ЁЯУМ Key Investor Considerations

  • Copper is a cyclical commodity, with prices closely tied to global economic activity, infrastructure spending, renewable energy expansion, and electric vehicle (EV) adoption.

  • As a PSU, Hindustan Copper’s performance is influenced by government policy decisions, capacity expansion plans, and potential disinvestment or strategic initiatives.

  • The stock may experience short‑term volatility, particularly during sharp movements in international copper prices or broader commodity cycles.

  • Long‑term returns depend on successful mine expansion, operational efficiency, cost control, and sustained domestic demand growth.

For the live share price, detailed financial ratios, technical analysis, or a long‑term investment perspective, let me know what you’d like to explore next.

Comments

Post a Comment

Popular posts from this blog

Champion (2025) Movie Review

Image
  Champion (2025) Movie Review Director: Reema Kagti Cast: Shahid Kapoor, Kiara Advani, Manoj Bajpayee Genre: Sports Drama Runtime: 2h 18m Language: Hindi Overview Champion is an electrifying sports drama that masterfully combines the thrill of competitive sports with a deeply emotional personal journey. Shahid Kapoor delivers a standout performance as Arjun, a determined underdog boxer who fights not just for victory, but for his self-respect and long-held dreams. Kiara Advani shines as the love interest and guiding force, providing emotional depth and mentorship, while Manoj Bajpayee adds gravitas in a pivotal supporting role. Action and Cinematography The film truly excels in its action sequences. Every boxing match is meticulously choreographed, featuring realistic punches, close-up shots, and well-timed slow-motion moments that fully immerse viewers. Cinematography captures the raw energy of the training gyms, the sweat and struggle of preparation, and the grandeur of ch...
Read more

Why would politicians deny Americans proven medical care?рд░ाрдЬрдиेрддा рдЕрдоेрд░िрдХिрдпों рдХो рдк्рд░рдоाрдгिрдд рдЪिрдХिрдд्рд╕ा рд╕ेрд╡ा рд╕े рд╡ंрдЪिрдд рдХ्рдпों рд░рдЦेंрдЧे?

 Why Politicians Deny Americans Proven Medical Care Politicians may withhold access to proven medical care for many reasons. These decisions are seldom rooted in medical evidence or concern for patient well-being; instead, they often reflect struggles over ideology, economics, cultural values, and political strategy. A closer look at healthcare policymaking reveals that the forces behind these denials are deeply interconnected. 1. Cost and Budget Concerns Many treatments and medications are costly to provide at scale. Politicians focused on reducing public spending may argue that covering them would place an unsustainable burden on taxpayers or strain programs like Medicare and Medicaid. For example, life-saving drugs for rare diseases or advanced cancer therapies often carry enormous price tags. Instead of pursuing ways to negotiate or regulate pricing, some leaders restrict coverage or access, leaving patients caught between medical need and financial limitation. Similar argument...
Read more

Why do some people think Obamacare penalizes those who save money, and what’s the reality for people with chronic illnesses? рдХुрдЫ рд▓ोрдЧ рдРрд╕ा рдХ्рдпों рд╕ोрдЪрддे рд╣ैं рдХि рдУрдмाрдоाрдХेрдпрд░ рдЙрди рд▓ोрдЧों рдХो рджंрдбिрдд рдХрд░рддा рд╣ै рдЬो рдкैрд╕ा рдмрдЪाрддे рд╣ैं, рдФрд░ рджीрд░्рдШрдХाрд▓िрдХ рдмीрдоाрд░िрдпों рд╕े рдкीрдб़िрдд рд▓ोрдЧों рдХे рд▓िрдП рд╡ाрд╕्рддрд╡िрдХрддा рдХ्рдпा рд╣ै?

 The Affordable Care Act, Savings, and Chronic Illness: Perceptions and Realities A recurrent critique of the Affordable Care Act (ACA), or “Obamacare,” is that it implicitly disadvantages individuals who have accumulated financial savings, despite the program’s stated goal of expanding equitable access to health care. This perception arises from the structure of the law’s premium subsidy framework. Subsidies under the ACA are calculated on the basis of modified adjusted gross income (MAGI), a measure that excludes household assets or accumulated savings. Consequently, individuals whose reported income exceeds subsidy thresholds—whether derived from wages, pensions, or investment withdrawals—may find themselves ineligible for premium assistance, even if their actual disposable resources are constrained. By contrast, a household with minimal savings but a comparatively lower reported income may receive substantial subsidies. To middle-income savers, this dynamic can appear punitive,...
Read more